Saba Capital Sells 5,776 ECAT Shares at $16.51 — Form 4 Report
Saba Capital Management, L.P. reported a sale of 5,776 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) on 09/16/2025 at $16.51 per share.
Rhea-AI Filing Summary
Saba Capital Management, L.P. reported a sale of 5,776 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) on 09/16/2025 at $16.51 per share. After the transaction the filer reports beneficial ownership of 27,849,571 shares held indirectly. The Form 4 is signed by representatives Zachary Gindes and Boaz Weinstein on 09/17/2025, and the filing indicates the reporting person is a director and a 10% owner.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale of a very small number of shares relative to large indirect holdings; appears to be compliance reporting.
The Form 4 documents a single non-derivative sale of 5,776 ECAT common shares at $16.51 on 09/16/2025 by Saba Capital Management, L.P. The filer continues to report substantial indirect beneficial ownership of 27,849,571 shares. There is no additional context in the filing about the reason for the sale or any derivative transactions. Given the small size of the sale relative to the reported holding, the transaction is unlikely to be material to ECAT's capitalization by itself; the filing primarily fulfils Section 16 disclosure requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,776 | $16.51 | $95K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Saba Capital report for ECAT (BlackRock ESG Capital Allocation Term Trust)?
Was the reported ECAT transaction a purchase or a sale?
When was the Form 4 signed and by whom?
Does the filing show any derivative transactions or additional context for the sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.